Armata Pharmaceuticals (ARMP) Cash from Financing Activities (2016 - 2026)
Quarterly results put Cash from Financing Activities at $641000.0 for Q1 2026, down 93.58% from a year ago — trailing twelve months through Mar 2026 was $16.3 million (up 62.46% YoY), and the annual figure for FY2025 was $25.6 million, down 26.73%.
Armata Pharmaceuticals has reported Cash from Financing Activities over the past 13 years, most recently at $641000.0 for Q1 2026.
- Cash from Financing Activities reached $641000.0 in Q1 2026 per ARMP's latest filing, down from $658000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $44.6 million in Q1 2022 and bottomed at -$500000.0 in Q4 2022.
- Median Cash from Financing Activities over the past 5 years was $641000.0 (2026), compared with a mean of $10.6 million.
- Peak annual rise in Cash from Financing Activities hit 79916.13% in 2023, while the deepest fall reached 152.05% in 2023.
- Over 5 years, Cash from Financing Activities stood at -$500000.0 in 2022, then skyrocketed by 91.4% to -$43000.0 in 2023, then crashed by 41.86% to -$61000.0 in 2024, then soared by 1178.69% to $658000.0 in 2025, then fell by 2.58% to $641000.0 in 2026.
- Business Quant data shows Cash from Financing Activities for ARMP at $641000.0 in Q1 2026, $658000.0 in Q4 2025, and $15.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -802.20 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 15.71 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | 641,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 641,000.00 |
| Mar 31, 2026 | 641,000.00 |
| Dec 31, 2025 | 658,000.00 |
| Dec 31, 2025 | 658,000.00 |
| Sep 30, 2025 | 14.97 Mn |
| Sep 30, 2025 | 14.97 Mn |
| Mar 31, 2025 | 9.99 Mn |
| Mar 31, 2025 | 9.99 Mn |
| Sep 30, 2024 | -61,000.00 |
| Sep 30, 2024 | -61,000.00 |
| Jun 30, 2024 | 88,000.00 |
| Jun 30, 2024 | 88,000.00 |
| Mar 31, 2024 | 34.93 Mn |
| Mar 31, 2024 | 34.93 Mn |
| Dec 31, 2023 | -43,000.00 |
| Dec 31, 2023 | -43,000.00 |
| Sep 30, 2023 | 24.81 Mn |
| Sep 30, 2023 | 24.81 Mn |
| Jun 30, 2023 | -368,000.00 |
| Jun 30, 2023 | -368,000.00 |
| Mar 31, 2023 | 29.59 Mn |
| Mar 31, 2023 | 29.59 Mn |
| Dec 31, 2022 | -500,000.00 |
| Dec 31, 2022 | -500,000.00 |
| Sep 30, 2022 | 31,000.00 |
| Sep 30, 2022 | 31,000.00 |
| Jun 30, 2022 | -146,000.00 |
| Jun 30, 2022 | -146,000.00 |
| Mar 31, 2022 | 44.63 Mn |
| Mar 31, 2022 | 44.63 Mn |
| Dec 31, 2021 | 7.04 Mn |
| Dec 31, 2021 | 7.04 Mn |
| Sep 30, 2021 | 86,000.00 |
| Sep 30, 2021 | 86,000.00 |
| Jun 30, 2021 | -185,000.00 |
| Jun 30, 2021 | -185,000.00 |
| Mar 31, 2021 | 18.58 Mn |
| Mar 31, 2021 | 18.58 Mn |
| Dec 31, 2020 | 432,000.00 |
| Dec 31, 2020 | 432,000.00 |
| Sep 30, 2020 | 60,000.00 |
| Sep 30, 2020 | 60,000.00 |
| Jun 30, 2020 | 306,000.00 |
| Jun 30, 2020 | 306,000.00 |
| Mar 31, 2020 | 22.41 Mn |
| Mar 31, 2020 | 22.41 Mn |
| Jun 30, 2019 | 9.98 Mn |
| Jun 30, 2019 | 9.98 Mn |
| Mar 31, 2019 | -1.00 Mn |
| Mar 31, 2019 | -1.00 Mn |
| Dec 31, 2018 | 6.09 Mn |
| Dec 31, 2018 | 6.09 Mn |
| Sep 30, 2018 | -44,000.00 |
| Sep 30, 2018 | -44,000.00 |
| Jun 30, 2018 | -204,000.00 |
| Jun 30, 2018 | -204,000.00 |
| Mar 31, 2018 | 6.61 Mn |
| Mar 31, 2018 | 6.61 Mn |
| Dec 31, 2017 | -206,000.00 |
| Dec 31, 2017 | -206,000.00 |
| Sep 30, 2017 | -611,000.00 |
| Sep 30, 2017 | -611,000.00 |
| Jun 30, 2017 | 9.69 Mn |
| Jun 30, 2017 | 9.69 Mn |
| Mar 31, 2017 | -205,000.00 |
| Mar 31, 2017 | -205,000.00 |
| Dec 31, 2016 | 3.26 Mn |
| Dec 31, 2016 | 3.26 Mn |
| Sep 30, 2016 | -17,000.00 |
| Sep 30, 2016 | -17,000.00 |